Dennis Souverein has a total of 152 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Risk factors for acquisition and severity of Acanthamoeba and Fusarium keratitis in contact lens users—A case–control and clinical–epidemiological study, 2009–2020

    by Laurène Peckeu‐Abboud, Anna C. Randag, Jeroen van Rooij, Dennis Souverein, Henny Otten, Robert P. L. Wisse, Claudy Oliveira dos Santos, Cathrien A. Eggink, Paul E. Verweij, Barbara Schimmer

    Purpose: Since 2015, the uncommon yet severe Acanthamoeba keratitis (AK) and Fusarium keratitis (FK) have increased in the Netherlands, predominantly in contact lens (CL) users. We investigated risk factors for acquisition and severity of AK and FK among CL users. Methods: For this retrospective case–control study, we approached AK and FK cases diagnosed in 16 cornea reference centres between 2009 and 2019. CL‐wearing controls were recruited in 2020 through social media. Besides, we assessed risk factors for treatment failure (corneal transplantation and/or final visual acuity ≤0.25) among cases included in the case–control study. Odds ratios (OR) with 95% confidence intervals (95%CI) were computed in multivariable logistic regression analyses. Results: The case–control study comprised 220 cases (181 AK, 39 FK) and 1020 controls. Identified risk factors were previous eye injury (OR: 16.0, 95%CI: 3.4–76.7), occupational/recreational surface water contact (OR: 9.1, 95%CI: 3.5–23.2), cleaning/rinsing CLs with tap water (OR: 3.3, 95%CI: 1.7–6.4), cigarette smoke exposure (OR: 1.9, 95%CI: 1.1–3.5) and napping in CLs (OR: 1.9, 95%CI: 1.0–3.6). Treatment failure occurred in 85/179 (47%) AK and 23/35 (66%) FK cases. Evisceration or enucleation was performed in 9/179 (5%) AK and 5/35 (14%) FK cases. Age > 42 years (OR: 5.6, 95%CI: 2.3–14.6), hard CL use (OR: 3.3, 95%CI: 1.0–14.0), corticosteroid eye drops prior to diagnosis (OR: 3.8, 95%CI: 1.5–10.5) and a ring infiltrate at diagnosis (OR: 15.3, 95%CI: 4.8–57.4) were associated with AK treatment failure. Conclusion: Identified preventable risks warrant enhanced communication between eye care providers and CL wearers promoting healthy CL wear and care practices. Increased awareness among ophthalmologists is needed to prevent corticosteroid treatment prior to AK diagnosis to reduce treatment failure.


  • Open Access

    Retrospective Surveillance of Cryptosporidium Species, Giardia Lamblia and Entamoeba Histolytica in the Netherlands (2015-2024): Epidemiological Trends and Disease Burden Updates

    by Elise M. J. Groenen, Thomas J. Roodsant, Alaa Al-Dawaf, Nicolaas L. A. Arents, Aldert Bart, Guido J. H. Bastiaens, M.S. Berends, Kim J. M. van Bergen, Danielle Hanssen, David J. Hetem, et al.

    Background: Cryptosporidium species and Giardia lamblia are endemic gastrointestinal pathogens worldwide, whereas Entamoeba histolytica is less commonly endemic, but can cause invasive disease. Due to limited surveillance of these parasites, epidemiological data in the Netherlands are scarce. Hence, we conducted a retrospective analysis of Nucleic Acid Amplification Test (NAAT) results to assess the incidence, disease burden, seasonality, and epidemiological trends of these infections.Methods: This retrospective, nationally representative cohort study analysed NAAT results from 24 medical microbiology laboratories (MMLs) (2015–2024) to estimate the incidence of Cryptosporidium species, G. lamblia, and E. histolytica, and to quantify the disease burden of human cryptosporidiosis and giardiasis in disability-adjusted life years (DALY) in the Netherlands. The study included all individuals tested for these parasites at participating MMLs. National incidence was estimated by extrapolating the population covered by MMLs, using NAAT-to-population ratios from six laboratories with known catchment sizes.Findings: A total of 9,373 Cryptosporidium species, 20,898 G. lamblia and 417 E. histolytica cases were identified, leading to an estimated mean incidence of 9.75 (95% CI: 9.56–9.95), 21.80 (21.40–22.00) and 0.43 (0.39–0.48) per 100,000 population, respectively. The annual disease burden (undiscounted DALYs) ranged from 74 (95% CI: 28-143) to 378 (95%CI: 150-694) for cryptosporidiosis (2020–2023), and from 233 (131–442) to 500 (275–950) for giardiasis (2021–2019). Cryptosporidium species and G. lamblia infections peaked in summer/fall and were most common in children, while E. histolytica incidence was low, non-seasonal, and significantly higher in men, affecting both children and adults.Interpretation: The persistently high disease burden of giardiasis and the recent, strong seasonal rise in cryptosporidiosis, highlight the need for enhanced surveillance, including genotyping and travel history, to guide public health interventions. Although E. histolytica incidence is low, its potential severity may warrant targeted measures such as contact tracing.


  • Open Access

    What is Weight Loss after Bariatric Surgery Expressed in Percentage Total Weight Loss (%TWL)? An Updated Systematic Review

    by Rutger Franken, Felix Hers, Redouan El Ajraoui, Kelly Tieken, Ralph de Vries, Dennis Souverein, Max Nieuwdorp, Victor Gerdes, Arnold van de Laar

    Percentage total weight loss (%TWL) is a robust and widely used outcome measure for assessing weight loss after metabolic and bariatric surgery (MBS). This study is an update of the 2021 systematic review on weight loss after MBS expressed in %TWL, now including results of one anastomosis gastric bypass (OAGB), Roux-en-Y gastric bypass (RYGB), and sleeve gastrectomy (SG). A total of 4,541 records were screened, and 49 studies were included, comprising both cohort and registry-based data. Descriptive pooled estimates suggested that OAGB was associated with the highest nadir %TWL within the first two years, whereas nadir %TWL appeared comparable between RYGB and SG. During longer-term follow-up, OAGB appeared to maintain a higher pooled mean %TWL than RYGB and SG. These findings should be interpreted cautiously given the heterogeneity of included studies and the limited availability of long-term data. They should be balanced against long-term complications and need for revisional surgery, which were beyond the scope of the present review. Standardized reporting and high-quality studies with extended follow-up using %TWL as the primary outcome are needed to improve comparability and interpretation of long-term weight loss after bariatric surgery.


  • Open Access

    Control of a hospital outbreak with methicillin-resistant Staphylococcus argenteus in The Netherlands, June–September 2023

    by Serena Slavenburg, Dennis Souverein, Sandra Witteveen, Esther de Vries, Angela de Haan, Annelot F. Schoffelen, Daan W. Notermans, Bjorn L. Herpers, Antoni P. A. Hendrickx

    Staphylococcus argenteus belongs to the Staphylococcus aureus complex and causes similar disease. Methicillin-resistant S. argenteus (MRSArg) is rare in the Netherlands. We describe the first hospital outbreak and its management. After a healthcare worker linked to a patient with MRSArg bacteremia tested positive, cohort screening of healthcare workers, patients, and family members was performed. Carriers received eradication therapy. Whole-genome multilocus sequence typing (wgMLST) and antimicrobial susceptibility testing were used to characterize isolates and mupirocin resistance. Fifteen (2.6%) MRSArg carriers were detected: 9/317 (2.8%) healthcare workers, 4/238 (1.7%) patients, 2/16 (12.5%) family members; age range 22-88 years, median 55 years. Nine (60%) were complicated and six (40%) uncomplicated carriers. After transfer of one initially negative patient to a nursing home, subsequent positivity led to two carriers among nursing home staff. wgMLST confirmed a single outbreak cluster of 15 isolates, all MLST ST2250. The isolates carried mecA, dfrG, and blaZ, but not PVL. Eradication therapy was started in 13/15 (86.7%) persons, with 84.6% (11/13) successful eradication. Six isolates carried a V588F-mutated ileS gene and had mupirocin MICs of 2-32 mg/L; nine were sensitive. We report the first successfully controlled MRSArg hospital outbreak in the Netherlands. The outbreak strain was clonally related and showed low-level mupirocin resistance linked to a mutated ileS gene. This work supports the importance of infection prevention and control measures that are applied for MRSA are also effective for MRSArg.

  • Open Access

    The Impact of a Structured Outpatient Parenteral Antimicrobial Therapy (OPAT) Programme on Quality of Care, Optimisation of Antimicrobial Use, and Healthcare Costs: A Retrospective Cohort Study

    by Irene G. Manders, Darya Comello, Dennis Souverein, Sjoerd Euser, Bjorn L. Herpers, Judith Vetten, Jayant S. Kalpoe, Marco Goeijenbier, Steven F. L. van Lelyveld

    Background/Objectives: In 2022, Spaarne Gasthuis hospital implemented an outpatient parenteral antimicrobial therapy (OPAT) programme, including mandatory infectious disease (ID) specialist assessment and integrated structured workflow, aiming to improve quality of care, optimize antimicrobial use, and reduce healthcare costs. Our objective was to evaluate the impact of the OPAT programme on patient outcomes (IV duration, clinical response, adverse clinical outcomes, timely peripherally inserted central catheter (PICC) removal), antimicrobial stewardship parameters, and healthcare costs. Methods: This retrospective before–after cohort study used electronic health record data to compare patients treated with outpatient parenteral antimicrobial therapy before (2019) and after (August 2022–December 2024) OPAT programme implementation. Using linear and logistic regression analyses, the association between the independent variable (pre-OPAT vs. OPAT) and outcomes were assessed and adjusted for potential confounders (sex, age, department, primary and additional indications). Cost analysis was performed, and ID specialist-recommended therapy adjustments were evaluated. Results: In total, 529 patients were included: 118 in the pre-OPAT group, and 411 in the OPAT group. In 36.3% of OPAT cases, therapy was adjusted, thereby optimizing antimicrobial stewardship. The OPAT programme was associated with significantly shorter IV therapy duration of 13.97 (mean) days (95%CI −9.15–−18.79; p < 0.001), significantly less meropenem use (p < 0.001), and significantly less adverse clinical outcomes (OR 0.58, 95%CI 0.37–0.92; p = 0.021), whereas no significant difference was found in clinical response (OR 1.22; 95%CI 0.67–2.32; p = 0.527). The programme led to cost savings of 3.343 EUR per patient. Conclusions: The OPAT programme optimized antimicrobial use and reduced IV therapy duration, adverse clinical outcomes, and healthcare costs.


  • Open Access

    Post COVID-19 Pandemic Increased Detection of Mycoplasma Pneumoniae in Adults Admitted to the Intensive Care

    by M. Goeijenbier, S. van der Bie, D. Souverein, D. Bolluyt, M. Nagel, S. P. Stoof, B. Vermin, J. Weenink, E. C. M. van Gorp, S. Euser, et al.

    Background: Mycoplasma pneumoniae (M. pneumoniae) infections can progress to severe respiratory complications, necessitating intensive care treatment. Recent post COVID-19 pandemic surges underscore the need for timely diagnosis, given potential diagnostic method limitations. Methods: A retrospective case series analysis was conducted on M. pneumonia PCR-positive patients admitted to two Dutch secondary hospitals’ ICUs between January 2023 and February 2024. Clinical presentations, treatments, outcomes, and mechanical ventilation data were assessed. Results: Seventeen ICU-admitted patients were identified, with a median age of 44 years, primarily due to hypoxia. Non-invasive ventilation was effective for most, while five required invasive mechanical ventilation. None of the patients required extracorporeal membrane oxygenation. No fatalities occurred. Post-PCR, treatment was adjusted to doxycycline or azithromycin; seven received steroid treatment. Discussion: Increased ICU admissions for M. pneumoniae infection were observed. Diverse clinical and radiological findings emphasize heightened clinical awareness. Early molecular diagnostics and tailored antibiotic regimens are crucial since beta-lactam antibiotics are ineffective. Conclusion: This study highlights the escalating challenge of severe M. pneumoniae infections in ICUs, necessitating a multifaceted approach involving accurate diagnostics, vigilant monitoring, and adaptable treatment strategies for optimal patient outcomes.


  • Open Access

    Similar Sensitivity of SARS-CoV-2 Detection in Oropharyngeal/Nasopharyngeal and Saliva Samples on the Hologic Panther Platform

    by Ali Vahidnia, Dennis Souverein, Sjoerd M. Euser, Milly Haverkort, Elise Noordhuis, Thomas Z. I. van Zijl, Jayant Kalpoe, Jan C. Sinnige, Bjorn L. Herpers

    Background: Oropharyngeal (OP) and nasopharyngeal (NP) sampling has historically been considered the reference specimen type used for respiratory virus detection. Saliva could be a less invasive alternative for SARS-CoV-2 detection, but limited evidence is available. Methods: The technical and clinical performance of saliva was compared to OP/NP on the Hologic Panther platform with two Aptima assays, the End-Point Transcription-Mediated Amplification assay (EP-TMA) and Real-Time Transcription-Mediated Amplification assay (RT-TMA). The samples were collected at the Public Health Service Testing Site XL location in Schiphol Amsterdam Airport. At the site, the Regional Public Health Laboratory Kennemerland (RPHLK) has a fully equipped laboratory facility. Results: A total of 374 samples (187 OP/NP swabs and 187 saliva samples) were collected from 187 unique patients. The Real-Time Transcription-Mediated Amplification assay (RT-TMA) resulted in comparable sensitivities for the detection of SARS-CoV-2 in both the OP/NP swabs (88.3%; 113/128) and saliva samples (87.5%; 112/128). The End-Point Transcription-Mediated Amplification assay (EP-TMA) analyses showed a similar sensitivity (86.7%; 111/128) in the OP/NP swabs but a lower sensitivity in the saliva samples (80.5%; 103/128). Within the discordant analyses, we found no associations in the symptoms, earlier SARS-CoV-2 infections and eating, smoking, drinking and tooth brushing habits within one hour before testing. Conclusions: The Hologic Panther platform Real-Time Transcription-Mediated Amplification assay (RT-TMA) yields a sensitivity for the detection of SARS-CoV-2 in saliva that is comparable to the OP/NP swabs derived from participants presenting themselves at a public health testing facility with minimal or mild symptoms.


  • The role of Dutch guidelines in the diagnostic outcomes and treatment decisions of hospitalised older adults with a suspected urinary tract infection: a retrospective cohort study

    by C. Eecen, R. Vreeswijk, D. Souverein, S. M. Euser, K. J. Kalisvaart

    Key summary points AbstractSection Aim To evaluate the applicability of the urinary tract infection (UTI) diagnostic and treatment guidelines of the Dutch Association of Urology (NVU) and Dutch Association of Elderly Care Physicians (Verenso) in hospitalised older adults with suspected UTI in terms of diagnostic outcomes and treatment decisions. AbstractSection Findings Adherence to either the NVU or the Verenso guidelines suggested that fewer antibiotics would have been prescribed in our study population. However, implementing the Verenso guideline in hospitals would demand a shift from diagnostic testing to focusing on urinary tract-related symptoms. AbstractSection Message Compliance with the NVU or the Verenso guidelines may have resulted in fewer antibiotic prescriptions in the study population.

  • Open Access

    Initial Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load Is Associated With Disease Severity: A Retrospective Cohort Study

    by Dennis Souverein, Karlijn van Stralen, Steven van Lelyveld, Claudia van Gemeren, Milly Haverkort, Dominic Snijders, Robin Soetekouw, Erik Kapteijns, Evelien de Jong, Gonneke Hermanides, et al.

    Background: We assessed the association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load and hospital admission, intensive care unit (ICU) admission, and in-hospital mortality. Methods: All SARS-CoV-2–positive persons with a combined nasopharyngeal and oropharyngeal swab that was collected between 17 March 2020 and 31 March 2021 in public health testing facilities were included. Results: From 20 207 SARS-CoV-2–positive persons, 310 (1.5%) were hospitalized within 30 days. High viral loads (crossing point [Cp] 30), adjusted for age and sex (adjusted odds ratio [aOR], 1.57 [95% confidence interval {CI}, 1.11–2.26]). The same association was seen for ICU admission (aOR, 7.06 [95% CI, 2.15–43.57]). The median [interquartile range] Cp value of the 17 patients who died in hospital was significantly lower compared to the 226 survivors (22.7 [3.4] vs 25.0 [5.2]). Conclusions: Higher initial SARS-CoV-2 viral load is associated with an increased risk of hospital admission, ICU admission, and in-hospital mortality. Our findings emphasize the added value of reporting SARS-CoV-2 viral load or cycle threshold/Cp values to identify persons who are at the highest risk of adverse outcomes such as hospital or ICU admission and who therefore may benefit from more intensive monitoring or early initiation of antiviral therapy.


  • Open Access

    The Effect of Varying Interval Definitions on the Prevalence of SARS-CoV-2 Reinfections: A Retrospective Cross-Sectional Cohort Study

    by Sjoerd M. Euser, Tieme Weenink, Jan M. Prins, Milly Haverkort, Irene Manders, Steven van Lelyveld, Bjorn L. Herpers, Jan Sinnige, Jayant Kalpoe, Dominic Snijders, et al.

    Background: We assessed the SARS-CoV-2 reinfection rate in a large patient cohort, and evaluated the effect of varying time intervals between two positive tests on assumed reinfection rates using viral load data. Methods: All positive SARS-CoV-2 samples collected between 1 March 2020 and 1 August 2021 from a laboratory in the region Kennemerland, the Netherlands, were included. The reinfection rate was analyzed using different time intervals between two positive tests varying between 2 and 16 weeks. SARS-CoV-2 PCR crossing point (Cp) values were used to estimate viral loads. Results: In total, 679,513 samples were analyzed, of which 53,366 tests (7.9%) were SARS-CoV-2 positive. The number of reinfections varied between 260 (0.52%) for an interval of 2 weeks, 89 (0.19%) for 4 weeks, 52 (0.11%) for 8 weeks, and 37 (0.09%) for a minimum interval of 16 weeks between positive tests. The median Cp-value (IQR) in the second positive samples decreased when a longer interval was chosen, but stabilized from week 8 onwards. Conclusions: Although the calculated reinfection prevalence was relatively low (0.11% for the 8-week time interval), choosing a different minimum interval between two positive tests resulted in major differences in reinfection rates. As reinfection Cp-values stabilized after 8 weeks, we hypothesize this interval to best reflect novel infection rather than persistent shedding.